Artelo Biosciences Inc.
13F holders, Q1 2024 (March 31)7holders
$1.50avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Artelo Biosciences Inc. in their 13F filings. The largest holders were Geode Capital Management, LLC ($30K), Tower Research Capital LLC (TRC) ($7K) and UBS Group AG ($185).
- Company
- Artelo Biosciences Inc.
- CUSIP
- 04301G508
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $185 |
| Exits | 1 | $9 |
Ownership 7 holders
| Geode Capital Management, LLC | 0.00% | No change | 19,808 | $30K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1.4% | 4,868 | $7K |
| UBS Group AG | 0.00% | New | 125 | $185 |
| Wells Fargo & Company | 0.00% | Add +13.6% | 25 | $37 |
| Morgan Stanley | 0.00% | No change | 20 | $30 |
| Rothschild Investment LLC | 0.00% | No change | 8 | $12 |
| NewEdge Advisors, LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is ARTELO BIOSCIENCES INC's weight in each manager's 13F, not the share of Artelo Biosciences Inc. the manager owns.